Other costimulation pathways blockade such as CD28-CD80/CD86 and OX40/OX40-L have previously demonstrated decreased pulmonary and dermal fibrosis in SSc mouse models [40, 41, 43]. This evidence concerns the gene CD28 and systemic sclerosis.